Northern Trust’s Boundless Bio BOLD Stock Holding History

Northern Trust’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-189,475	Closed	-$227K	–	4551
2025 Q4	$227K	Sell	189,475 -1,326	-0.7%	-$1.65K	﹤0.01%	3936
2025 Q3	$235K	Sell	190,801 -16,699	-8%	-$19.3K	﹤0.01%	3925
2025 Q2	$210K	Sell	207,500 -107,865	-34%	-$143K	﹤0.01%	3921
2025 Q1	$476K	Buy	315,365 +217,353	+222%	+$451K	﹤0.01%	3591
2024 Q4	$284K	Buy	98,012 +40,434	+70%	+$118K	﹤0.01%	3868
2024 Q3	$200K	Buy	+57,578	New	+$209K	﹤0.01%	3896

Other funds holding BOLD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Northern Trust's BOLD Position: Q1 2026 in Review

Northern Trust sold out of Boundless Bio (BOLD) in Q1 2026, closing a stake of 189,475 shares — an estimated $227K sold.

Northern Trust first reported a position in BOLD in Q3 2024 and held it in 6 quarters. The position peaked at $476K in Q1 2025. 36 funds tracked by Wall St. Rank hold BOLD as of Q1 2026.

Northern Trust reported no remaining Boundless Bio position as of Q1 2026 after selling out during the quarter.
Northern Trust sold 189,475 Boundless Bio shares in Q1 2026, an estimated $227K.
Northern Trust first reported a position in Boundless Bio in Q3 2024 and held it in 6 quarters.
Northern Trust's Boundless Bio position peaked at $476K in Q1 2025.
36 funds tracked by Wall St. Rank held Boundless Bio as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.